{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:52:43Z","timestamp":1792223563555,"version":"4.4.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"11","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.medcli.2013.11.027","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T15:48:12Z","timestamp":1390924092000},"page":"512-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Profilaxis de la encefalopat\u00eda hep\u00e1tica"],"prefix":"10.1016","volume":"142","author":[{"given":"Rosa M.","family":"Morillas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2013.11.027_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: The modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.medcli.2013.11.027_bib0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1478-3231.2010.02273.x","article-title":"Rat CCl4-induced cirrhosis plus total portal vein ligation: A new model for the study of hyperammonaemia and brain oedema","volume":"30","author":"Miquel","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.medcli.2013.11.027_bib0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","article-title":"Treatment of hepatic encephalopathy","volume":"337","author":"Riordan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.11.027_bib0020","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disacharides for hepatic encephalopathy: Systematic review of randomised trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2013.11.027_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.medcli.2013.11.027_bib0030","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3748\/wjg.v18.i17.2084","article-title":"Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats","volume":"18","author":"Odena","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.medcli.2013.11.027_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1345\/aph.1K436","article-title":"Rifaximin for treatment of hepatic encephalopathy","volume":"43","author":"Maclayton","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medcli.2013.11.027_bib0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1592\/phco.28.8.1019","article-title":"Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy","volume":"28","author":"Lawrence","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medcli.2013.11.027_bib0045","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MEG.0b013e328302f470","article-title":"Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: A meta-analysis","volume":"20","author":"Jiang","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2013.11.027_bib0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.11.027_bib0055","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0168-8278(10)60197-3","article-title":"Rifaximin decreases venous ammonia concentrations and time-weighted average ammonia concentrations correlate with overt hepatic encephalopathy (HE) as assess by Conn score in a 6-month study","volume":"52","author":"Sanyal","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2013.11.027_bib0060","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-8278(10)60017-7","article-title":"Rifaximin treatment improved quality of life in patients with hepatic encephalopathy: Results of a large, randomized, placebo-controlled trial","volume":"52","author":"Sanyal","year":"2010","journal-title":"J Hepatol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313008592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313008592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T02:01:40Z","timestamp":1538877700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313008592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0025775313008592"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2013.11.027","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profilaxis de la encefalopat\u00eda hep\u00e1tica","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2013.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}